Brogan Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$499K Buy
1,704
+10
+0.6% +$3.29K 0.22% 27
2025
Q4
$594K Buy
1,694
+8
+0.5% +$2.7K 0.26% 23
2025
Q3
$545K Buy
1,686
+9
+0.5% +$2.8K 0.23% 27
2025
Q2
$652K Buy
1,677
+7
+0.4% +$2.82K 0.29% 19
2025
Q1
$726K Buy
1,670
+7
+0.4% +$2.81K 0.35% 16
2024
Q4
$613K Buy
1,663
+7
+0.4% +$2.93K 0.3% 15
2024
Q3
$861K Buy
1,656
+6
+0.4% +$3.21K 0.49% 13
2024
Q2
$894K Buy
1,650
+5
+0.3% +$2.64K 0.56% 12
2024
Q1
$853K Buy
1,645
+5
+0.3% +$2.49K 0.56% 13
2023
Q4
$773K Buy
1,640
+5
+0.3% +$2.31K 0.57% 12
2023
Q3
$712K Hold
1,635
0.63% 11
2023
Q2
$726K Hold
1,635
0.62% 11
2023
Q1
$752K Hold
1,635
0.65% 10
2022
Q4
$839K Buy
+1,635
New +$830K 0.75% 8

Other funds holding ELV

Brogan Financial's ELV Position: Q1 2026 in Review

Brogan Financial increased its Elevance Health (ELV) stake by 0.59% in Q1 2026, buying an estimated $3.29K and bringing the position to 1,704 shares worth $499K. The position accounts for 0.22% of the portfolio, ranked #27.

Brogan Financial first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. The position peaked at $894K in Q2 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Brogan Financial held 1,704 shares of Elevance Health worth $499K as of Q1 2026.
  • Brogan Financial bought 10 Elevance Health shares in Q1 2026, an estimated $3.29K.
  • Elevance Health made up 0.22% of Brogan Financial's portfolio in Q1 2026, its #27 holding.
  • Brogan Financial first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
  • Brogan Financial's Elevance Health position peaked at $894K in Q2 2024.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Brogan Financial's 13F filing for Q1 2026, filed 11 May 2026.